Consolidated Balance Sheets - USD ($) $ in Millions		Sep. 30, 2022		Dec. 31, 2021
Assets
Investments, at fair value		$ 15,791.8	[1]	$ 16,101.0
Cash		264.0		258.0
Foreign currency, at fair value (cost—$2 and $119, respectively)		2.0		119.0
Receivable for investments sold and repaid		425.0		567.0
Income receivable		165.0		153.0
Unrealized appreciation on foreign currency forward contracts		39.0		9.0
Deferred financing costs		22.0		16.0
Prepaid expenses and other assets		7.0		5.0
Total assets		16,716.0		17,228.0
Liabilities
Payable for investments purchased		57.0		2.0
Debt (net of deferred financing costs of $36 and $38, respectively)	[2]	9,137.0		9,142.0
Unrealized depreciation on foreign currency forward contracts		0.0		1.0
Stockholder distributions payable		190.0		176.0
Management fees payable		61.0		60.0
Subordinated income incentive fees payable	[3]	25.0		19.0
Administrative services expense payable		7.0		5.0
Interest payable		67.0		70.0
Other accrued expenses and liabilities		12.0		23.0
Total liabilities		9,556.0		9,498.0
Commitments and Contingencies	[4]
Stockholders' equity
Preferred stock, $0.001 par value, 50,000,000 shares authorized, none issued and outstanding		0.0		0.0
Common stock, $0.001 par value, 750,000,000 shares authorized, 282,978,008 and 284,543,091 shares issued and outstanding, respectively		0.0		0.0
Capital in excess of par value		9,625.0		9,658.0
Retained earnings (accumulated deficit)	[5]	(2,465.0)		(1,928.0)
Total stockholders' equity		7,160.0	[6]	7,730.0
Total liabilities and stockholders' equity		$ 16,716.0		$ 17,228.0
Net asset value per share of common stock at period end (in dollars per share)		$ 25.30		$ 27.17
Non-controlled/unaffiliated investments
Assets
Investments, at fair value		$ 12,552.0		$ 12,558.0
Non-controlled/affiliated investments
Assets
Investments, at fair value		439.2		859.0
Controlled/affiliated investments
Assets
Investments, at fair value		$ 2,801.3		$ 2,684.1

[1] Security may be an obligation of one or more entities affiliated with the named company

[2] See Note 9 for a discussion of the Company’s financing arrangements.

[3] See Note 2 and 4 for a discussion of the methodology employed by the Company in calculating the subordinated income incentive fees.

[4] See Note 10 for a discussion of the Company’s commitments and contingencies.

[5] See Note 5 for a discussion of the sources of distributions paid by the Company.

[6] See Note 8 for additional information regarding the fair value of the Company's financial instruments